Investor Relations

Company Overview

Procaps Group has experience in the development of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies that reach more than 50 countries in all five continents. We have direct presence in 13 countries in Latin America and we have more than 5,000 collaborators working under a sustainable model.

We develop, manufacture, and market over-the-counter (OTC) and prescription drugs, nutritional supplements and high-potential clinical solutions.

Investor Contact Information

Company

Procaps Group
9 Rue de Bitbourg
L-1273 Luxembourg
Grand Duchy of Luxembourg

Investor Relations

Chris Tyson/Doug Hobbs
SPAC Alpha IR+
T: 949-491-8235
LATN@mzgroup.us

Procaps Group Company Contact
Maria Alejandra Molina
Legal Compliance Director
T: (57)(5) 3719162)
mamolina@procaps.com.co